Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (221-230 of 320) with videos related to

Pageof 32
Sort By:
The Journal of Pathology|August 29, 2022
The proteome of clear cell ovarian carcinomaJennifer X Ji, Dawn R Cochrane, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2011
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancerMichael S Anglesio, Joshy George, Hagen Kulbe, et al.
Human Pathology|May 4, 2020
Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinomaBasile Tessier-Cloutier, Dawn R Cochrane, Anthony N Karnezis, et al.
The Oncologist|May 9, 2014
Diagnostic value of next-generation sequencing in an unusual sphenoid tumorFarzad Jamshidi, Erin Pleasance, Yvonne Li, et al.
Iscience|February 5, 2025
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic typeJessica D Lang, William Selleck, Shawn Striker, et al.
The Journal of Pathology|September 11, 2015
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic typeAnthony N Karnezis, Yemin Wang, Pilar Ramos, et al.
Journal of the National Cancer Institute|February 3, 2016
Synchronous Endometrial and Ovarian Carcinomas: Evidence of ClonalityMichael S Anglesio, Yi Kan Wang, Madlen Maassen, et al.
EMBO Reports|November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Plos One|July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancersMichael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
Pageof 32

Showing results (221-230 of 320) with videos related to

Sort By:
Pageof 32
The Journal of Pathology|August 29, 2022
The proteome of clear cell ovarian carcinomaJennifer X Ji, Dawn R Cochrane, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2011
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancerMichael S Anglesio, Joshy George, Hagen Kulbe, et al.
Human Pathology|May 4, 2020
Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinomaBasile Tessier-Cloutier, Dawn R Cochrane, Anthony N Karnezis, et al.
The Oncologist|May 9, 2014
Diagnostic value of next-generation sequencing in an unusual sphenoid tumorFarzad Jamshidi, Erin Pleasance, Yvonne Li, et al.
Iscience|February 5, 2025
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic typeJessica D Lang, William Selleck, Shawn Striker, et al.
The Journal of Pathology|September 11, 2015
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic typeAnthony N Karnezis, Yemin Wang, Pilar Ramos, et al.
Journal of the National Cancer Institute|February 3, 2016
Synchronous Endometrial and Ovarian Carcinomas: Evidence of ClonalityMichael S Anglesio, Yi Kan Wang, Madlen Maassen, et al.
EMBO Reports|November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Plos One|July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancersMichael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
Pageof 32